Cite
Genomic, phenotypic, and clinical safety of Limosilactobacillus reuteri ATCC PTA 4659.
MLA
Sendelius, Malin, et al. “Genomic, Phenotypic, and Clinical Safety of Limosilactobacillus Reuteri ATCC PTA 4659.” Journal of Industrial Microbiology & Biotechnology, vol. 50, no. 1, Feb. 2023. EBSCOhost, https://doi.org/10.1093/jimb/kuad041.
APA
Sendelius, M., Axelsson, J., Liu, P., & Roos, S. (2023). Genomic, phenotypic, and clinical safety of Limosilactobacillus reuteri ATCC PTA 4659. Journal of Industrial Microbiology & Biotechnology, 50(1). https://doi.org/10.1093/jimb/kuad041
Chicago
Sendelius, Malin, Jakob Axelsson, Peidi Liu, and Stefan Roos. 2023. “Genomic, Phenotypic, and Clinical Safety of Limosilactobacillus Reuteri ATCC PTA 4659.” Journal of Industrial Microbiology & Biotechnology 50 (1). doi:10.1093/jimb/kuad041.